Full-service regulatory and product development consulting firm for biologics, pharma and medical devices
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
60
NCT04777981
(CBDRA60) to Prevent or Reduce Symptoms of COVID-19 and Prevention of Post-Acute Sequelae of SARS-CoV-2 Infection PASC
Phase: N/A
Role: Collaborator
Start: Jul 1, 2022
Completion: Dec 28, 2022
Loading map...